NL-OMON34512撤回不适用
Hepcidin kinetics in hemodialysis patients. - Hepcidin and hemodialysis.
niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Adult hemodialysis patients (>18 yrs)
- •hemodialysis for at least 4 months
- •no IV iron or EPO during experimental dialysis sessions
排除标准
- •malignancies/ overt infection/ hepatic failure, gastro-intestinal bleeding and blood transfusion during the preceding 4 months
- •no informed consent
研究者
相似试验
招募中
不适用
Kinetics of extracellular vesicles in hemodialysisTissue injury and bio-incompatibility in hemodialysis10038430NL-OMON53277Vrije Universiteit Medisch Centrum6
已完成
1 期
Effect of Hemodialysis on the PK of JTZ-951 in Subjects With End-stage Renal DiseaseAnemia in Chronic Kidney DiseaseNCT01978587Akros Pharma Inc.6
尚未招募
不适用
pro-hepcidin and hepcidin levels in blood and urine of Gaucher patients in relation to iron homeostasis.Gaucherdisease and glucocerebrosidase deficiency10027424NL-OMON30063Academisch Medisch Centrum60
进行中（未招募）
1 期
Evaluation of HCV clearance by hemodialysisChronic hepatitis C in patients with chronic renal failureMedDRA version: 9.1Level: LLTClassification code 10008912Term: Chronic hepatitis CMedDRA version: 9.1Level: LLTClassification code 10066622Term: Chronic hemodialysisEUCTR2008-006772-30-ATMedical University of Graz
已完成
不适用
Influence of hemodialysis, hemodiafiltration and peritoneal dialysis on asymmetric dimethylarginine and markers of oxidative stressEnd stage renal diseaseMetabolic and Endocrine - DiabetesACTRN12611000577910Research Project No. MSM 0021620819, Ministry of Health, Czech Republic.60